Abbott rakes in earnings despite infant formula investigation but Nutrition suffers sales loss
date:Jul 22, 2022
Despite being embroiled in a nationwide scandal across the US over an investigation into numerous infant deaths and illnesses, Abbotts sales reached US$11.3 billion in its second quarter this year, marking a 14.3% organic sales growth.

Nonetheless, organic international and domestic sales in its nutrition segment suffered a 4.5% loss compared to the same period last year, reaching US$1.95 billion. Its Pediatric segment, more closely affiliated with the infant formula products, experienced a 13
1/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/19 11:21